To the Editor, Squamous cell carcinomas (SCCs) are the most common type of cancer capable of metastasis (Yan et al., 2011) . The enzymatic activity of Cox-2 (Cyclooxygenase 2, also called Ptgs2), contributes to the synthesis of prostanoids and is upregulated in numerous types of cancers, including cutaneous SCCs (cSCCs) (Subbaramaiah and Dannenberg, 2003; Sobolewski et al., 2010; Hua et al., 2015) . Cox-2 is an important regulator of tumor development and progression in ultraviolet and chemical carcinogenesis models of cSCC (Jiao et al., 2014b; a; Elmets, Ledet and Athar, 2014) . In addition to tumorigenesis, Cox-2 may also have the potential to mediate formation of a mesenchymal-like spindle cell form of cSCC, since previous studies have also shown that Cox-2 can also regulate epithelial-mesenchymal transition (EMT) (Bocca et al., 2014) .
Hair follicle stem cells (HFSCs) can act as cancer cells of origin for cSCCs upon expression of Kras G12D and loss of function in the tumor suppressor p53 (Lapouge et al., 2011; White et al., 2011) . Moreover, HFSC-originating cSCCs are primed to form mesenchymal-like cSCCs with morphological and gene expression characteristics of EMT in vivo ( Figure 1A ) (Latil et al., 2017; Pastushenko et al., 2018) . Upon global transcriptional analysis, Cox-2 was found to be significantly overexpressed in HFSC-originating cSCCs (White et al., 2011) , which was confirmed by qRT-PCR ( Figure 1B) .
In order to determine whether Cox-2 is required for HFSC-originating cSCC development, we crossed Ptgs2 flox/flox mice to Krt15-CrePR; LSL Kras G12D ; p53 flox/flox ; Rosa-LSL tdTomato mice ( Figure 1C -D, Figure S1 ). Similar to Cox-2 studies using DMBA/TPA-or UVB-induced cutaneous tumorigenesis in SKH-1 or 129S1+C57BL/6 mice, cutaneous tumors appeared in conditional knockout mice; however, tumor free survival was significantly improved ( Figure 1F ) (Tiano et al., 2002; Jiao et al., 2014b; a) . Gene deletion was confirmed in knockout tumor tissues, and protein levels of Cox-2 were found to be strongly suppressed when compared to Ptgs2 wild-type tumors ( Figure 1D , E).
Interestingly, there were strikingly distinct macroscopic features between Ptgs2 wild-type and knockout tumors (Figure 2A, B) . When macroscopic tumors are evident in this cSCC mouse model, they exhibit a smooth surface, grow rapidly, and often ulcerate within a relatively short period ( Figure 2A ). In contrast, Ptgs2 knockout tumors grew slowly and developed a rough surface ( Figure 2B ). Histopathological examination demonstrated that, similar to previous studies (Lapouge et al., 2011; White et al., 2011) , HFSC-originating cSCCs show mesenchymallike spindle cell carcinomas with minimal keratinization (11/15) more frequently than cSCCs with mixed mesenchymal-like and epithelial components (4/15) ( Figure 2C , E). On the other hand, Ptgs2 knockout tumors showed significantly different phenotypes compared to those expressing wild-type Ptgs2 (Fisher-Freeman-Halton test, *p<0.002), as they were frequently well-differentiated with significant hyperkeratosis or papillomatous growths (6/11), and less often, mixed (3/11) or mesenchymal-like only tumors (2/11) ( Figure 2D , E). Lineage tracing using the LSL tdTomato allele demonstrated that tumor cells in both Ptgs2 wild-type and knockout animals originated from Krt15-CrePR + HFSCs ( Figure 2C , 2D) .
Consistent with characteristics of EMT, Ptgs2 wild-type mesenchymal-like cSCCs express high levels of Vimentin, low or absent levels of E-Cadherin and lack of clear borders between stromal Pdgfr-α + fibroblasts and tumor cells ( Figure 2F , Figure S2 ). On the other hand, Ptgs2 knockout tumor cells show an absence of Vimentin staining, high levels of E-cadherin, and distinct borders between stromal and tumor cell compartments ( Figure 2G , Figure S2 ).
In vitro, tdTomato + positive tumor cells from Ptgs2 wild-type animals showed mesenchymal phenotypes with elongated cell bodies, indicating invasive potential ( Figure 2H , I) Latil et al., 2017; Pastushenko et al., 2018) . In contrast, Ptgs2 conditional knockout tumors demonstrated round cell bodies, and exhibited relatively reduced expression of mesenchymal markers (N-Cadherin, Vimentin) at the protein level ( Figure 2H , I). To begin to understand the potential role of Cox-2 activity on the mesenchymal-like phenotype of Krt15-CrePR; LSL Kras G12D ; p53 flox/flox cSCCs cells during tumor growth, we established primary cell lines ( Figure S3A, B ). Pharmacological suppression of Cox-2 by a selective Cox-2 inhibitor (Celecoxib) in vitro was confirmed by PGE 2 ELISA assay and Cox-2 immunoblot ( Figure S3C , D) and resulted in a small and transient increase in E-cadherin, but no apparent changes in Ncadherin expression ( Figure S3E ). Additionally, Celecoxib treatment demonstrates a change in cell morphology in vitro, from elongated spindle-shaped to large, often multi-nucleated cells suggesting potential induction of cellular senescence ( Figure S3F ). These data indicate that primary cSCC cell lines do not exhibit a full mesenchymal to epithelial transition when Cox-2 is suppressed in vitro, but future experiments will be needed to further explore this finding, since this system does not faithfully recapitulate the microenvironment of cSCC in vivo.
Taken together, oncogenic Ras/p53 expression in Krt15-CrePR + HFSCs can induce formation of advanced cSCCs with mesenchymal characteristics; however, loss of Cox-2 function significantly suppresses EMT-like characteristics in HFSC-originating tumors and causes a conversion to tumors that possess epithelial characteristics at high frequency ( Figure   2J ). While Cox-2 is required for advanced SCC formation from tumor-prone HFSCs, this phenotype may not be reversible solely by Cox-2 inhibition, or may primarily be useful at early stages of spindle cell cSCC initiation. 
Materials and Methods

Animals
Mice were acquired from Jackson Labs (Krt15-CrePR, LSL tdTomato, Ptgs2 flox/flox ) (Morris et al., 2004; Ishikawa and Herschman, 2006; and the National Cancer Institute Mouse Models of Human Cancers Consortium repository ( LSL Kras G12D and p53 flox/flox ) (Johnson et al., 2001; Jonkers et al., 2001) . All animals were properly maintained following a protocol approved by the Institutional Animal Care and Use Committee (IACUC) and the Animal Research Committee at Cornell University. Krt15-CrePR; LSL Kras G12D ; p53 flox/flox ; Ptgs2 wt/wt ; LSL tdTomato and Krt15-CrePR; LSL Kras G12D ; p53 flox/flox ; Ptgs2 flox/flox ; LSL tdTomato animals were generated from our previous work (Moon et al., 2019) and treated by intraperitoneal injections at approximately seven weeks of age with RU486, also known as mifepristone. A working solution of RU486 was dissolved in corn oil at 10 mg/mL, and 200 µL per day was injected for 3 consecutive days.
Genotyping and quantitative RT-PCR
Mouse tail snips were collected at around 11 days postnatal per IACUC approved procedures, and at the time of tumor collection for genotype confirmation. The collected tissues were digested in 0.05N NaOH at 95 o C for 1 hour followed by neutralization with 1M Tris-HCl at pH 8.
Genotyping PCR was performed using Taq Polymerase and supplied 10x buffer (G-Biosciences), dNTPS (G-Biosciences) and using the primers in Supplementary Table 1 . For qRT-PCR, RNA was isolated from tissue samples using Trizol (Thermo Fisher Scientific), cDNA was synthesized using SuperScript IV First Strand Synthesis System (Thermo Fisher Scientific). Quantitative PCR was performed using PerfeCTa SYBR Green supermix (Quantabio) and primers listed in Supplementary Table 1 , and data was analyzed using the delta Ct method.
Bioinformatics analysis of gene set enrichment
We used data from GSM1253528 and GSM1253530 acquired from a dataset in . After downloading .cel files, we collapsed the dataset using probe information provided by the manufacturer and applied 'median_of_probe' option to minimize bias. Gene Set Enrichment Analysis (GSEA) preranked was used to identify expression changes and gene enrichment on EMT (Subramanian et al., 2007) .
Tissue immunostaining and immunoblotting
Formalin-fixed and paraffin-embedded (FFPE, 5 µm) or OCT-embedded frozen (8-10 µm) tissue sections were used for histology and immunostaining. The immunofluorescence signal was amplified using Alexa Fluor secondary antibodies. Fluoroshield with DAPI mounting medium was used for counter staining. For immunoblotting, tissues were lysed using whole cell lysis buffer along with a homogenizer. Protease inhibitors were freshly added to the lysis buffer right before harvesting tissues. Total protein concentration was determined using BCA assay and a microplate reader following manufacturer's instructions. Tissue lysates (20 µg) mixed with sample buffer and denatured at 95 o C for 5 min were resolved on SDS-PAGE gels, then transferred onto a PVDF membrane. Blocking was performed with 5% BSA for 1 hour before primary antibody incubation. Signal was detected using peroxidase-conjugated secondary antibodies together with an enhanced chemiluminescent horseradish peroxidase substrate. The Cox-2 antibody was obtained from Cayman Chemical, α-tubulin from Novus, Pdgfr-α from Thermo Fisher Scientific and Krt14, E-Cad, N-Cad and Vim from Biolegend. Alexa Fluor 488 and 594 secondary antibodies according to primary antibody species were obtained from Thermo Fisher Scientific.
Cell culture and Treatment
To establish primary cell lines from mesenchymal-like SCCs, we used a transplantation method in NOD scid gamma mice (NSG). To confirm that the cells to be transplanted originated from mesenchymal-like SCCs with characteristics of EMT, we performed immunostaining with Krt5 and Vimentin. Primary SCC cells were harvested and cultured in DMEM with 10% FBS and pen/strep. Primary cells isolated from transplanted cSCCs within 6 passages were used in this study. Cells were treated with a Cox-2 selective inhibitor, Celecoxib (Cayman Chemical), which was dissolved in 0.1% Dimethyl sulfoxide (DMSO) and provided to cultured cells at 30µM (Bock et al., 2007; Moon et al., 2019) for 0, 24, 48, 60 and 72 hours.
Enzyme-linked immunosorbent assay (ELISA)
Conditioned media was collected to measure the level of PGE 2 using a PGE 2 ELISA Kit (cat. #514010, Cayman Chemical). For conditioned media, SCC cells were cultured in the absence or presence of 30 µM celecoxib for the above indicated times (0, 24, 48, 60, and 72 hours). Each sample was assayed in triplicate and in two independent experiments, and data was normalized to cell number. The plate was read using a BioTek Synergy 2 plate reader at an absorbance of 410nm and analyzed with Gen5 Software, in accordance with the manufacturer's instructions.
Statistics analysis
